首页> 外国专利> A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET CD70-POSITIVE TUMORS

A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET CD70-POSITIVE TUMORS

机译:一种工程天然杀伤细胞的方法,靶向CD70阳性肿瘤

摘要

Embodiments of the disclosure include methods and compositions related to targeting of CD70-expressing cells with NK cells specifically engineered to bind the CD70 antigen. In particular embodiments, NK cells that are manipulated to expressing CD70-targeting engineered receptors, such as CARs, are utilized to target cancers that express CD70. In certain embodiments, vectors that express the CD70-targeting CARs also express particular a suicide gene and/or one or more particular cytokines.
机译:本公开内容的实施方案包括与特异性设计的NK细胞靶向CD70表达细胞的方法和组合物与结合CD70抗原。在特定实施方案中,被操纵以表达CD70靶向工程受体的NK细胞,例如汽车,用于靶向表达CD70的癌症。在某些实施方案中,表达CD70靶向汽车的载体还表达了特定的自杀基因和/或一种或多种特定的细胞因子。

著录项

  • 公开/公告号WO2021142127A1

    专利类型

  • 公开/公告日2021-07-15

    原文格式PDF

  • 申请/专利权人 BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM;

    申请/专利号WO2021US12510

  • 发明设计人 REZVANI KATY;

    申请日2021-01-07

  • 分类号A61K48;C12N5/071;A61K39/395;A61K39;A61K45;C12N15;C12N5/16;C07H21/04;

  • 国家 US

  • 入库时间 2022-08-24 19:58:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号